Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood (Q33492255)

27 July 2017

title

Impaired fibrinolysis in the hemolytic-uremic syndrome of childhood (English)

1 reference

hemolytic-uremic syndrome

27 July 2017

main subject

1 reference

D Menzel

1

1 reference

27 July 2017

M Levi

2

1 reference

27 July 2017

G Dooijewaard

3

1 reference

27 July 2017

M Peters

4

1 reference

27 July 2017

J W ten Cate

5

1 reference

27 July 2017

publication date

1 January 1994

1 reference

27 July 2017

1 reference

27 July 2017

volume

68

1 reference

27 July 2017

issue

1

1 reference

27 July 2017

page(s)

43-48

1 reference

Proceedings: The release of plasminogen activator and factor VIII to lysine vasopressin, arginine vasopressin, I-desamino-8-d-arginine vasopressin, angiotensin and oxytocin in man.

27 July 2017

cites work

1 reference

12 December 2020

DDAVP induces systemic release of urokinase-type plasminogen activator

1 reference

12 December 2020

Proteolytic cleavage of single-chain pro-urokinase induces conformational change which follows activation of the zymogen and reduction of its high affinity for fibrin

1 reference

12 December 2020

Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells

1 reference

12 December 2020

Fibrinolytic response to tumor necrosis factor in healthy subjects

1 reference

12 December 2020

Plasma inhibitor of glomerular fibrinolysis in the hemolytic-uremic syndrome

1 reference

12 December 2020

Haemolytic uraemic syndrome

1 reference

12 December 2020

Fibrinolytic activity in end-stage renal disease

1 reference

12 December 2020

Quantitation of urokinase antigen in plasma and culture media by use of an ELISA

1 reference

12 December 2020

Absent factor VIII response to synthetic vasopressin analogue (DDAVP) in nephrogenic diabetes insipidus

1 reference

12 December 2020

A proenzyme form of human urokinase

1 reference

12 December 2020

A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow

1 reference

12 December 2020

Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome

1 reference

12 December 2020

Release of both urokinase and tissue plasminogen activator from veins in vitro

1 reference

12 December 2020

Fibrinolytic capacity in hemodialysis patients treated with recombinant human erythropoietin

1 reference

12 December 2020

Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools

1 reference

12 December 2020

Platelet-activating factor secreted by DDAVP-treated monocytes mediates von Willebrand factor release from endothelial cells

1 reference

12 December 2020

Granulocyte elastase, tumor necrosis factor-alpha and urokinase levels as prognostic markers in severe infection

1 reference

12 December 2020

A simple, sensitive spectrophotometric assay for extrinsic (tissue-type) plasminogen activator applicable to measurements in plasma

1 reference

12 December 2020

Behaviour and quantitation of extrinsic (tissue-type) plasminogen activator in human blood

1 reference

12 December 2020

Fibrinolytic activators and inhibitors in terminal renal insufficiency and in anephric patients

1 reference

12 December 2020

Effects of hypoxia and acidosis on vascular plasminogen activator release in the pig ear perfusion system.

1 reference

12 December 2020

Immunoelectron microscopic localization of type 1 plasminogen activator inhibitor on the surface of activated endothelial cells

1 reference

12 December 2020

Urokinase-type plasminogen activator: proenzyme, receptor, and inhibitors

1 reference

12 December 2020

The haemolytic uraemic syndrome: a review

1 reference

12 December 2020

Tissue plasminogen activator

1 reference

12 December 2020

Role of plasminogen-activator inhibitor type 1 in the pathogenesis and outcome of the hemolytic uremic syndrome

1 reference

12 December 2020

Thrombin generation and fibrinolysis in the thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome.

1 reference

12 December 2020

Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase

1 reference

12 December 2020

Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo

1 reference

12 December 2020

Demonstration of a fast-acting inhibitor of plasminogen activators in human plasma

1 reference

12 December 2020

Fibrinolytic and haemostatic responses to desamino-D-arginine vasopressin (DDAVP) administered by intravenous and subcutaneous routes in healthy subjects

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01695919

1 reference

27 July 2017

1 reference